Michele Cilli

6.0k citations

108 papers · 4.0k indexed · h-index 37

Impact in

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Neurology top 2%
- Neuroblastoma Research and Treatments

Papers in

Neurology 36
- Neuroblastoma Research and Treatments 34
Cancer Research 17
- Cancer, Hypoxia, and Metabolism 11

Co-authors: Mirco Ponzoni Fabio Pastorino Chiara Brignole Doménico Ribatti Danilo Marimpietri Gabriella Pagnan Daniela Di Paolo Federica Piccardi
Journals: PLoS ONE (6 papers)Clinical Cancer Research (5 papers)International Journal of Cancer (5 papers)Oncotarget (5 papers)Cancer Research (4 papers)
Partner nations: Italy United States United Kingdom

In The Last Decade

Michele Cilli

108 papers receiving 4.0k citations

Peers

Countries citing papers authored by Michele Cilli

Since Specialization

Citations

This map shows the geographic impact of Michele Cilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Cilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Cilli more than expected).

Fields of papers citing papers by Michele Cilli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Cilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Cilli. The network helps show where Michele Cilli may publish in the future.

Co-authors

The 25 scholars most cited alongside Michele Cilli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michele Cilli Line = papers co-authored together Michele Cilli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma Journal for ImmunoTherapy of Cancer ·Chiara Brignole, Enzo Calarco, Veronica Bensa, Elena Giusto, Patrizia Perri, Eleonora Ciampi, Maria Valeria Corrias, Simonetta Astigiano, Michele Cilli, Derik Loo, Ezio Bonvini, Fabio Pastorino, Mirco Ponzoni	2023	16
2	Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity Pharmaceutical Research ·Maurizio Viale, Graziella Vecchio, Massimiliano Monticone, Vittorio Bertone, Valentina Giglio, Irena Maric, Michele Cilli, Vittorio Bocchini, Aldo Profumo, Mirco Ponzoni, Laura Emionite, Mattia Rocco	2019	13
3	A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy Molecular Cancer Therapeutics ·Viktoryia Sidarovich, Marilena De Mariano, Sanja Aveic, Michael Pancher, Valentina Adami, Pamela Gatto, Silvia Pizzini, Luigi Pasini, Michela Croce, Federica Parodi, Flora Cimmino, Marianna Avitabile, Laura Emionite, Michele Cilli, Silvano Ferrini, Aldo Pagano, Mario Capasso, Alessandro Quattrone, Gian Paolo Tonini, Luca Longo	2018	29
4	Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model OncoImmunology ·Paola Bocca, Emma Di Carlo, Ignazio Caruana, Laura Emionite, Michele Cilli, Biagio De Angelis, Concetta Quintarelli, Annalisa Pezzolo, Lizzia Raffaghello, Fabio Morandi, Franco Locatelli, Vito Pistoia, Ignazia Prigione	2017	95
5	The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients Cancer Research ·Alice Bartolini, Daniela Di Paolo, Alessio Noghero, Daniele Murgia, Angela Rita Sementa, Michele Cilli, Renata Pasqualini, Wadih Arap, Federico Bussolino, Mirco Ponzoni, Fabio Pastorino, Serena Marchiò	2015	18
6	Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model Investigational New Drugs ·Maurizio Viale, Marta Rossi, Eleonora Russo, Michele Cilli, Anna Aprile, Aldo Profumo, Pierluigi Santi, Carla Fenoglio, Sergio Cafaggi, Mattia Rocco	2015	15
7	Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity Molecular Cancer ·Giulia Pinton, Arcangela Gabriella Manente, Antonio Daga, Michele Cilli, Maurizio Rinaldi, Stefan Nilsson, Laura Moro	2014	15
8	Bone Turnover in Wild Type and Pleiotrophin-Transgenic Mice Housed for Three Months in the International Space Station (ISS) PLoS ONE ·Sara Tavella, Alessandra Ruggiu, Alessandra Giuliani, Francesco Brun, Barbara Canciani, Adrian Mănescu, Katia Marozzi, Michele Cilli, Delfina Costa, Yi Liu, Federica Piccardi, Roberta Tasso, Giuliana Tromba, F. Rustichelli, Ranieri Cancedda	2012	71
9	Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells Cell Research ·Annalisa Pezzolo, Federica Parodi, Danilo Marimpietri, Lizzia Raffaghello, Claudia Cocco, Angela Pistorio, Manuela Mosconi, Claudio Gambini, Michele Cilli, Silvia Deaglio, Fabio Malavasi, Vito Pistoia	2011	54
10	The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response Clinical Cancer Research ·Gabriella Pagnan, Daniela Di Paolo, Roberta Carosio, Fabio Pastorino, Danilo Marimpietri, Chiara Brignole, Annalisa Pezzolo, Monica Loi, Luis J. V. Galietta, Federica Piccardi, Michele Cilli, Beatrice Nico, Doménico Ribatti, Vito Pistoia, Mirco Ponzoni	2009	38
11	Short-Time Survival and Engraftment of Bone Marrow Stromal Cells in an Ectopic Model of Bone Regeneration Tissue Engineering Part A ·Paolo Giannoni, Silvia Scaglione, Antonio Daga, Cristina Ilengo, Michele Cilli, Rodolfo Quarto	2009	61
12	Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin Clinical Cancer Research ·Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, Beatrice Nico, Doménico Ribatti, Antonio Daga, Gabriella Baio, Carlo E. Neumaier, Chiara Brignole, Monica Loi, Danilo Marimpietri, Gabriella Pagnan, Michele Cilli, Eugene A. Lepekhin, Seema V. Garde, Renato Longhi, Angelo Corti, Theresa M. Allen, Jinzi J. Wu, Mirco Ponzoni	2008	74
13	In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo Investigational New Drugs ·Angela Alama, Maurizio Viale, Michele Cilli, Cristina Bruzzo, Federica Novelli, Bruno Tasso, Fabio Sparatore	2008	16
14	Ligand-Targeted Liposomal Therapies of Neuroblastoma Current Medicinal Chemistry ·Fabio Pastorino, Danilo Marimpietri, Chiara Brignole, Daniela Di Paolo, Gabriella Pagnan, Antonio Daga, Federica Piccardi, Michele Cilli, Theresa M. Allen, Mirco Ponzoni	2007	26
15	Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy Cancer Research ·Fabio Pastorino, Chiara Brignole, Daniela Di Paolo, Bice Nico, Annalisa Pezzolo, Danilo Marimpietri, Gabriella Pagnan, Federica Piccardi, Michele Cilli, Renato Longhi, Doménico Ribatti, Angelo Corti, Theresa M. Allen, Mirco Ponzoni	2006	192
16	The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cancer Epidemiology and Prevention Biomarkers ·Beatrice E. Bachmeier, Michael Nerlich, Cristina M. Iancu, Michele Cilli, Roberta Venè, Raffaella Dell’Eva, Marianne Jochum, Adriana Albini, Ulrich Pfeffer	2006	3
17	Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc Cancer Gene Therapy ·L.C. Boffa, Giovanna Cutrona, Michele Cilli, Serena Matis, Gianluca Damonte, M. Mariani, Enrico Millo, Maria Cristina Moroni, Silvio Roncella, Franco Fedeli, Manlio Ferrarini	2006	28
18	Tumor Cells Engineered with IL-12 and IL-15 Genes Induce Protective Antibody Responses in Nude Mice The Journal of Immunology ·Anna Maria Orengo, Emma Di Carlo, Alberto Comes, Marina Fabbi, Tiziana Piazza, Michele Cilli, Piero Musiani, Silvano Ferrini	2003	19
19	TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis International Journal of Cancer ·Piera Valente, Gianfranco Fassina, A Melchiori, Luciana Masiello, Michele Cilli, Angelo Vacca, Maurizio Onisto, Leonardo Santi, William G. Stetler‐Stevenson, Adriana Albini	1998	233
20	Ligand-Independent Tyrosine Phosphorylation of the Receptor Encoded by thec-neuOncogene Growth Factors ·Carla Boccaccio, Giovanni Gaudino, Michele Cilli, Anna Mondino, Paolo M. Comoglio	1991	4

About Michele Cilli

Michele Cilli is a scholar working on Neurology, Cancer Research, Oncology, Immunology and Genetics, having authored 108 papers that have together received 4.0k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (34 papers), Cancer, Hypoxia, and Metabolism (11 papers), Cancer therapeutics and mechanisms (10 papers), Immune Cell Function and Interaction (9 papers), Mesenchymal stem cell research (7 papers), Virus-based gene therapy research (7 papers), Cell death mechanisms and regulation (7 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Cancer Research (658 citations), Neurology (535 citations), Oncology (933 citations), Biomaterials (426 citations) and Immunology (658 citations). Michele Cilli has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Mirco Ponzoni, Fabio Pastorino, Chiara Brignole, Doménico Ribatti, Danilo Marimpietri, Gabriella Pagnan, Daniela Di Paolo, Federica Piccardi, Laura Emionite and Adriana Albini. Their work appears in journals such as PLoS ONE, Clinical Cancer Research, International Journal of Cancer, Oncotarget and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact